Differential host inflammatory responses to viable versus antibiotic- killed bacteria in experimental microbial sepsis

Infection and Immunity

Volumn 68, Issue 4, 2000, Pages 2301-2308

  Silverstein, Richard ^a,e   Wood, John G ^b   Xue, Qiao ^a   Norimatsu, Mari ^a,f   Horn, David L ^c,g   Morrison, David C ^a,d,e  

^a UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF KANSAS MEDICAL CENTER   (United States)

^c MERCK RESEARCH LABORATORIES   (United States)

^d UNIVERSITY OF MISSOURI KANSAS CITY SCHOOL OF MEDICINE   (United States)

^e ST LUKE S HOSPITAL   (United States)

^f INSTITUTE FOR ANIMAL HEALTH   (United Kingdom)

^g BRISTOL MYERS SQUIBB   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CEFTAZIDIME; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBIOTIC THERAPY; ARTICLE; BACTERICIDAL ACTIVITY; CELL INTERACTION; CELL KILLING; CELL PROTECTION; CELL VIABILITY; CONTROLLED STUDY; ENDOTHELIUM CELL; GRAM STAINING; IMMUNE RESPONSE; INFLAMMATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; SEPSIS; STAPHYLOCOCCUS AUREUS; STRAIN DIFFERENCE;

ANIMALS; ANTI-BACTERIAL AGENTS; ANTI-INFLAMMATORY AGENTS; CEFTAZIDIME; CELL ADHESION; CELL MOVEMENT; CEPHALOSPORINS; DEXAMETHASONE; ENDOTHELIUM, VASCULAR; ESCHERICHIA COLI; FEMALE; GALACTOSAMINE; IMIPENEM; KINETICS; LEUKOCYTES; MALE; MICE; MICROCIRCULATION; RATS; RATS, SPRAGUE-DAWLEY; SEPSIS; STAPHYLOCOCCUS AUREUS; THIENAMYCINS; TIME FACTORS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0034100624     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.68.4.2301-2308.2000     Document Type: Article

References (47)

1. Amura, C. R., R. Silverstein, and D. C. Morrison. 1998. Mechanisms involved in the pathogenesis of sepsis are not necessarily reflected by in vitro cell activation studies. Infect. Immun. 66:5372-5378.
2. Beutler, B., N. Krochin, I. W. Milsark, C. Luedke, and A. Cerami. 1986. Control of cachectin (tumor necrosis factor) synthesis: mechanisms of endotoxin resistance. Science 232:977-980.
3. Bollaert, P.-E., C. Charpentier, B. Levy, M. Debouverie, G. Audibert, and A. Larcan. 1998. Reversal of late septic shock with supraphysiologic doses of hydrocortisone. Crit. Care Med. 26:645-650.
4. Buxton Hopkin, D. A. 1978. Frapper fort ou frapper doucement: a gram-negative dilemma. Lancet ii:1193-1194.
5. Chapes, S. K., and A. A. Beharka. 1995. Lipopolysaccharide is required for the lethal effects of enterotoxin B after D-galactosamine sensitization. J. Endotoxin Res. 2:263-271.
6. Croxton, F. E. 1953. Elementary statistics with applications in medicine, p. 235-239 and 326-327. Prentice-Hall, Inc., Englewood Cliffs, N.J.
7. Cusumano, V., G. Mancuso, F. Genovese, M. Cuzzola, J. A. Cook, J. B. Cochran, and G. Teti. 1997. Neonatal hypersusceptibility to endotoxin correlates with increased tumor necrosis factor production in mice. J. Infect. Dis. 176:168-176.
8. Davenpeck, K. L., J. Zagorski, R. P. Schleimer, and B. S. Bochner. 1998. Lipopolysaccharide-induced leukocyte rolling and adhesion in the rat mesenteric microcirculation: regulation by glucocorticoids and role of cytokines. J. Immunol. 161:5861-6870.
9. Davis, M. J. 1987. Determination of volumetric flow in capillary tubes using an optical Doppler velocimeter. Microvasc. Res. 34:223-230.
10. De Kimpe, S. J., M. Kengatharan, C. Thiemermann, and J. R. Vane. 1995. The cell wall components peptidoglycan and lipoteichoic acid from Staphylococcus aureus act in synergy to cause shock and multiple organ failure. Proc. Natl. Acad. Sci. USA 92:10359-10363.
11. Fiedler, V. B., I. Loof, V. Voehringer, C. Galanos, and M. A. Fournel. 1992. Monoclonal antibody to tumor necrosis factor-alpha prevents lethal endotoxin sepsis in adult rhesus monkeys. J. Lab. Clin. Med. 120:574-588.
12. Fischer, C. J., Jr., J. M. Agosti, S. M. Opal, S. F. Lowry, R. A. Balk, J. C. Sadoff, E. Abraham, R. M. H. Schein, and E. Benjamin for the Soluble TNF Receptor Sepsis Study Group. 1996. Treatment of septic shock with the tumor necrosis factor receptor:Fc fusion protein. N. Engl. J. Med. 334:1697-1702.
13. Freudenberg, M. A., and C. Galanos. 1991. Tumor necrosis factor alpha mediates lethal activity of killed gram-negative and gram-positive bacteria in D-galactosamine-treated mice. Infect. Immun. 59:2110-2115.
14. Frieling, J. T. M., J. A. Mulder, T. Hendriks, J. H. A. J. Curfs, C. J. van der Linden, and R. W. Sauerwein. 1997. Differential induction of pro- and anti-inflammatory cytokines in whole blood by bacteria: effects of antibiotic treatment. Antimicrob. Agents Chemother. 41:1439-1443.
15. Galanos, C., M. A. Freudenberg, T. Katschinski, R. Salamao, H. Mossmann, and Y. Kumazawa. 1992. Tumor necrosis factor and host response to endotoxin, p. 75-104. In J. L. Ryan and D. C. Morrison (ed.), Bacterial endotoxic lipopolysaccharides, vol. II. CRC Press, Inc., Boca Raton, Fla.
16. Galanos, C., M. A. Freudenberg, and W. Reutter. 1979. Galactosamine-induced sensitization to the lethal effects of endotoxin. Proc. Natl. Acad. Sci. USA 76:5939-5943.
17. Gao, J. J., E. G. Zuvanich, Q. Xue, D. L. Horn, R. Silverstein, and D. C. Morrison. 1999. Cutting edge: bacterial DNA and LPS act in synergy in inducing nitric oxide production in RAW 264.7 macrophages. J. Immunol. 163:4095-4099.
18. Gonzalez, J. C., D. C. Johnson, D. C. Morrison, M. A. Freudenberg, C. Galanos, and R. Silverstein. 1993. Endogenous and exogenous glucocorticoids have different roles in modulating endotoxin lethality in D-galactosamine-sensitized mice. Infect. Immun. 61:970-974.
19. Hinshaw, L. B., T. E. Emerson, Jr., F. B. Taylor, Jr., A. C. K. Chang, M. Duerr, G. T. Peer, D. J. Flournoy, G. L. White, S. D. Kosanke, C. K. Murray, R. Xu, R. B. Passey, and M. A. Fournel. 1992. Lethal Staphylococcus aureus-induced shock in primates: prevention of death with anti-TNF antibody. J. Trauma 33:568-573.
20. Horn, D. L., S. M. Opal, and E. Lomastro. 1996. Antibiotics, cytokines, and endotoxin: a complex and evolving relationship in gram-negative sepsis. Scand. J. Infect. Dis. Suppl. 101:9-13.
21. House, S. D., and H. H. Lipowsky. 1987. Leukocyte-endothelium adhesion: microhemodynamics in mesentery of the cat. Microvasc. Res. 34:363-379.
22. Jarisch, A. 1895. Therapeutiche versuche bei syphilis. Wien. Med. Wochenschr. 45:721-724.
23. Kirikae, T., M. Hirata, H. Yamasu, F. Kirikae, H. Tamura, F. Kayama, K. Nakatsuka, T. Yokochi, and M. Nakano. 1998. Protective effects of a human 18-kilodalton cationic antimicrobial protein (CAP18)-derived peptide against endotoxemia. Infect. Immun. 66:1861-1868.
24. Kurose, I., R. Wolf, M. B. Grisham, T. Y. Aw, R. D. Specian, and D. N. Granger. 1995. Microvascular responses to inhibition of nitric oxide production: role of active oxidants. Circ. Res. 76:30-39.
25. Marino, M. W., A. Dunn, D. Grail, M. Inglese, Y. Noguchi, E. Richards, A. Jungbluth, H. Wada, M. Moore, B. Williamson, S. Basu, and L. J. Old. 1997. Characterization of tumor necrosis factor-deficient mice. Proc. Natl. Acad. Sci. USA 94:8093-8098.
26. Marshall, A. J., and E. Y. Denkers. 1998. Toxoplasma gondii triggers granulocyte-dependent cytokine-mediated lethal shock in D-galactosamine-sensitized mice. Infect. Immun. 66:1325-1333.
27. Meduri, G. U., A. S. Headley, E. Golden, S. J. Carson, R. A. Umberger, T. Kelso, and E. A. Tolley. 1998. Effect of prolonged methylprednisolone therapy in unresolving acute respiratory distress syndrome. JAMA 280:159-165.
28. Mossmann, T. 1983. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Methods 65:55-63.
29. Newcomb, D., G. Bolgos, L. Green, and D. G. Remick. 1998. Antibiotic treatment influences outcome in murine sepsis: mediators of increased morbidity. Shock 10:110-117.
30. Norimatsu, M., and D. C. Morrison. 1998. Correlation of antibiotic-induced endotoxin release and cytokine production in Escherichia coli-inoculated mouse whole blood ex vivo. J. Infect. Dis. 177:1302-1307.
31. Opal, S. M., and J. Cohen. 1999. Clinical gram-positive sepsis: does it fundamentally differ from gram-negative sepsis? Clin. Care Med. 27:1608-1616.
32. Periti, P., and T. Mazzei. 1998. Antibiotic-induced release of bacterial cell wall components in the pathogenesis of sepsis and septic shock: a review. J. Chemother. 10:427-448.
33. Reed, L. J., and H. A. Muench. 1938. A simple method for estimating fifty percent endpoints. J. Hyg. 27:493-497.
34. Robinson, L. A., L. Tu, D. A. Steeber, O. Preis, J. L. Platt, and T. F. Tedder. 1998. The role of adhesion molecules in human leukocyte attachment to porcine vascular endothelium: implications for xenotransplantation. J. Immunol. 12:6931-6938.
35. Rothe, J., W. Lesslauer, H. Lötscher, Y. Lang, P. Koebel, F. Köntgen, A. Althage, R. Zinkernagel, M. Steinmetz, and H. Bluethmann. 1993. Mice lacking the tumour necrosis factor receptor 1 are resistant to TNF-mediated toxicity but highly susceptible to infection by Listeria monocytogenes. Nature 364:798-802.
36. Schneider, C. M., D. Huzly, C. Vetter, B. U. von Specht, and F. D. Daschner. 1997. Tumor necrosis factor alpha and interleukin 6 release induced by antibiotic killing of Pseudomonas aeruginosa and Staphylococcus aureus. Eur. J. Microbiol. Infect. Dis. 16:467-471.
37. Siegel, S. 1956. Nonparametric statistics, p. 96-100. McGraw-Hill Book Co., New York, N.Y.
38. Silverstein, R., W. M. Johnson, S. E. Bucklin, and D. C. Johnson. 1996. The protein kinase C activator PMA modulates LPS lethality in normal mice and protects against lethality in D-galactosamine-sensitized mice. J. Endotoxin Res. 3:29-37.
39. Silverstein, R., D. C. Johnson, and M. Norimatsu. 1999. Glucocorticoid control of endotoxin responses, p. 769. In H. Brade, S. M. Opal, S. N. Vogel, and D. C. Morrison (ed.), Endotoxin in health and disease. Marcel Dekker, Inc., New York, N.Y.
40. Silverstein, R., M. Norimatsu, and D. C. Morrison. 1997. Fundamental differences during gram-positive versus gram-negative sepsis become apparent during bacterial challenge of D-galactosamine-treated mice. J. Endotoxin Res. 4:173-181.
41. Silverstein, R., B. R. Turley, C. A. Christofferesen, D. C. Johnson, and D. C. Morrison. 1991. Hydrazine sulfate protects D-galactosamine-sensitized mice against endotoxin and tumor necrosis factor/cachectin lethality: evidence of a role for the pituitary. J. Exp. Med. 173:357-365.
42. Tiegs, G., M. A. Freudenberg, C. Galanos, and A. Wendel. 1992. Colchicine prevents tumor necrosis factor-induced toxicity in vivo. Infect. Immun. 60: 1941-1945.
43. Tracey, K. J., Y. Fong, D. G. Hesse, K. R. Manogue, A. T. Lee, G. C. Kuo, S. F. Lowry, and A. Cerami. 1987. Anti-cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteraemia. Nature 330:662-664.
44. van Langevelde, P., J. T. van Dissel, E. Ravensbergen, B. J. Appelmilk, I. A. Schrijver, and P. H. P. Groenveld. 1998. Antibiotic-induced release of lipoteichoic acid and peptidoglycan from Staphylococcus aureus: quantitative measurements and biological reactivities. Antimicrob. Agents Chemother. 42:3073-3078.
45. Wood, J. G., L. F. Mattioli, and N. C. Gonzalez. 1999. Hypoxia causes leukocyte adherence to mesenteric venules in nonacclimatized, but not in acclimatized, rats. J. Appl. Physiol. 87:873-881.
46. Zawacki, J. K., J. L. Hunt, R. L. Gamelli, and J. P. Filkins. 1997. Glucocorticoid regulation of hepatic TNF production following cecal ligation and puncture sepsis. Shock 8:141-145.
47. Zimmerman, B. J., J. W. Holt, J. C. Paulson, D. C. Anderson, M. Miyasaka, T. Tamatani, R. F. Todd, J. R. Rusche, and D. N. Granger. 1994. Molecular determinants of lipid mediator-induced leukocyte adherence and emigration in rat mesenteric venules. Am. J. Physiol. 266:H847-H853.